Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - MacroChem Corporation (NasdaqNM:MCHM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
110 Hartwell Avenue
Lexington, MA 02421
Phone: (781) 862-4003
Fax: (781) 862-4338
Employees (last reported count): 30
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 18%
·Over the last 6 months:
 · one insider sell; 3,000  shares
·Institutional: 10% (12% of float)
(48 institutions)
·Net Inst. Buying: 1.02M shares (+27.73%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
MacroChem Corporation develops pharmaceutical products for commercialization by applying SEPA (Soft Enhancer of Percutaneous Absorption), its patented topical drug delivery technology. SEPA compounds, when properly combined with drugs, provide pharmaceutical formulations (such as creams, gels and solutions) that enhance the transdermal delivery of drugs into the skin or into the bloodstream. SEPA compounds are designed to enhance the diffusion of drugs into and through the skin by making the outer layer of the skin more permeable to the drug molecule.
More from Market Guide: Expanded Business Description

Financial Summary
MacroChem Corp. engages in the development and commercialization of transdermal drug delivery compounds and systems designed to promote the delivery of drugs from the surface of the skin into the skin and bloodstream. For the six months ended 6/30/01, revenues fell from $572 thousand to $0. Net loss increased 22% to $6.6 million. Results reflect the termination by AHP of the Co.'s license agreement and increased research and development expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

John Zabriskie, Ph.D., 61
Chairman
--  
Robert Palmisano
Pres, CEO
--  
Bernard Patriacca
CFO, VP
--  
Kenneth Rice, Jr., 47
VP, Treasurer, Sec.
$170K
Paul Schechter, M.D., Ph.D., 61
VP, Drug Devel. & Regulatory Affairs
209K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:MCHMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Dec-2000
$2.25 
Recent Price$6.30 
52-Week High
on 1-June-2001
$10.81 
Beta1.84 
Daily Volume (3-month avg)329.4K
Daily Volume (10-day avg)247.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+12.0%
52-Week Change
relative to S&P500
+50.3%
Share-Related Items
Market Capitalization$165.7M
Shares Outstanding26.3M
Float21.6M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.49 
Earnings (ttm)-$0.45 
Earnings (mrq)-$0.13 
Sales (ttm)$0.00 
Cash (mrq)$0.50 
Valuation Ratios
Price/Book (mrq)12.92 
Price/EarningsN/A 
Price/Sales (ttm)2,629.82 
Income Statements
Sales (ttm)$58.0K
EBITDA (ttm)-$11.5M
Income available to common (ttm)-$10.9M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-75.01%
Return on Equity (ttm)-81.44%
Financial Strength
Current Ratio (mrq)8.31 
Debt/Equity (mrq)0 
Total Cash (mrq)$13.1M
Short Interest
As of 8-Aug-2001
Shares Short2.98M
Percent of Float13.8%
Shares Short
(Prior Month)
2.97M
Short Ratio19.13 
Daily Volume156.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.